Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,158,800
+$871,585 QoQ
Shares Held
923,626
+17.1% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. PRLD ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in PRLD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,158,800 | 923,626 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,287,215 | 788,695 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $219,215 | 152,233 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $125,376 | 154,977 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $141,056 | 183,667 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $295,594 | 231,839 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $117,851 | 56,933 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $164,344 | 43,135 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $287,229 | 60,597 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $248,872 | 58,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,592 | 12,813 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $176,805 | 39,290 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $127,993 | 22,455 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $313,463 | 51,898 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $698,022 | 105,601 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,168,423 | 223,836 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,244,842 | 180,412 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,520,536 | 282,774 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $289,621 | 10,116 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||